Emman Saeed, Khudaima Bibi, Sajid Mushtaq, Iqra Bibi, Ji-Ae Park
{"title":"Advancing Photodynamic Therapy: The Role of PET and SPECT in Imaging-Guided Theranostics.","authors":"Emman Saeed, Khudaima Bibi, Sajid Mushtaq, Iqra Bibi, Ji-Ae Park","doi":"10.1021/acs.molpharmaceut.5c00551","DOIUrl":null,"url":null,"abstract":"<p><p>Early cancer diagnosis is crucial for better treatment outcomes. Selecting the most effective therapy relies on accurate and specific diagnostic tools. Imaging plays a key role in evaluating new treatments, assessing disease progression, and monitoring tumor changes during therapy. It also aids in refining treatment strategies after completion. PDT shows significant promise in cancer treatment, using light-activated compounds to target cancer cells. Nuclear medicine techniques like PET and SPECT are particularly valuable for planning and monitoring PDT. Radiolabeled photosensitizers and clinically approved radiopharmaceuticals enable tracking of drug distribution and treatment effects, such as cell death, metabolism, and vascular damage. This review highlights the role of nuclear imaging in supporting PDT for cancer treatment.</p>","PeriodicalId":52,"journal":{"name":"Molecular Pharmaceutics","volume":" ","pages":""},"PeriodicalIF":4.5000,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acs.molpharmaceut.5c00551","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Early cancer diagnosis is crucial for better treatment outcomes. Selecting the most effective therapy relies on accurate and specific diagnostic tools. Imaging plays a key role in evaluating new treatments, assessing disease progression, and monitoring tumor changes during therapy. It also aids in refining treatment strategies after completion. PDT shows significant promise in cancer treatment, using light-activated compounds to target cancer cells. Nuclear medicine techniques like PET and SPECT are particularly valuable for planning and monitoring PDT. Radiolabeled photosensitizers and clinically approved radiopharmaceuticals enable tracking of drug distribution and treatment effects, such as cell death, metabolism, and vascular damage. This review highlights the role of nuclear imaging in supporting PDT for cancer treatment.
期刊介绍：
Molecular Pharmaceutics publishes the results of original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. The journal encourages contributions describing research at the interface of drug discovery and drug development.
Scientific areas within the scope of the journal include physical and pharmaceutical chemistry, biochemistry and biophysics, molecular and cellular biology, and polymer and materials science as they relate to drug and drug delivery system efficacy. Mechanistic Drug Delivery and Drug Targeting research on modulating activity and efficacy of a drug or drug product is within the scope of Molecular Pharmaceutics. Theoretical and experimental peer-reviewed research articles, communications, reviews, and perspectives are welcomed.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
